ALEXANDRA DAVIS: Open Payments
NPI 1093250805 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,735 in 63 payments from 16 companies in 2025. Trend: 2023 $1,719 · 2024 $2,094 · 2025 $1,735
Food & beverage: $1,635Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $343 |
| Arcutis Biotherapeutics, Inc. | 15 | $302 |
| Janssen Biotech, Inc. | 8 | $195 |
| Regeneron Healthcare Solutions, Inc. | 4 | $179 |
| Organon LLC | 7 | $156 |
| Lilly USA, LLC | 2 | $152 |
| UCB, Inc. | 1 | $126 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $88 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Biofrontera Inc. | 2 | $34 |
Products named: Zoryve, SKYRIZI, TREMFYA, VTAMA, DUPIXENT, Bimzelx, EBGLYSS, ILUMYA.
Industry payments across NV — which companies pay providers there.
